Treating acute coronary syndromes with new antiplatelet drugs: the mortality issue with prasugrel and ticagrelor

Author： De Servi Stefano   Navarese Eliano Pio   D’Urbano Maurizio   Savonitto Stefano  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.27, Iss.11, 2011-11, pp. : 2117-2122

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prasugrel vs. Ticagrelor in acute coronary syndromes: Which one to choose?

By Alber Hannes F.  

Wiener klinische Wochenschrift, Vol. 123, Iss. 15-16, 2011-08 ,pp. : 468-476

Springer Publishing Company

Access to resources Recommend Favorite

A critical overview on ticagrelor in acute coronary syndromes

By Navarese E.P.  

QJM: An International Journal of Medicine, Vol. 106, Iss. 2, 2013-02 ,pp. : 105-115

Oxford University Press

Access to resources Recommend Favorite

Developments in antiplatelet therapy for acute coronary syndromes and considerations for long-term management

By Cowley Michael J.   Kuritzky Louis  

Current Medical Research and Opinion, Vol. 25, Iss. 6, 2009-06 ,pp. : 1477-1490

Informa Healthcare

Access to resources Recommend Favorite

Tailoring Antiplatelet Therapy in Acute Coronary Syndromes: The Thin Red Line

By  

Cardiology, Vol. 126, Iss. 4, 2013-09 ,pp. : 230-232

Karger

Access to resources Recommend Favorite

Predictors of bleeding risk and long-term mortality in patients with acute coronary syndromes

By Cohen Marc  

Current Medical Research and Opinion, Vol. 21, Iss. 3, 2005-03 ,pp. : 439-446

Informa Healthcare

Access to resources Recommend Favorite